Carotid Artery Stenting With Proximal Cerebral Protection for Patients With Angiographic Appearance of String Sign  by Nikas, Dimitrios N. et al.
C
P
A
D
G
N
M
O
i
B
v
M
p
s
R
8
p
(
P
0
m
s
C
p
F
C
F
C
C
M
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 3 , N O . 3 , 2 0 1 0
© 2 0 1 0 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 9 8 / 1 0 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c i n . 2 0 0 9 . 1 1 . 0 1 8arotid Artery Stenting With Proximal Cerebral
rotection for Patients With Angiographic
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irano and Mercogliano, Italy; and Moscow, Russia
bjectives The aim of this study was to assess the safety and effectiveness of carotid artery stent-
ng (CAS) with proximal cerebral protection in patients showing string sign at carotid angiography.
ackground Presence of string sign is a well-known factor for adverse events in patients with se-
ere carotid artery disease undergoing CAS.
ethods We used retrospective analysis of a cohort of patients who underwent carotid angiogra-
hy with the intention to undergo carotid stenting and had angiographically documented string
ign in the target lesion.
esults From October 2006 to August 2007, 25 patients (21 men and 4 women, mean age 70.9 
.7 years) presented with string sign during carotid angiography. This was 6.0% of a total of 416
atients studied during the time of the study. Twenty patients (80.0%) were symptomatic, and 5
20.0%) were asymptomatic. Carotid artery stenting was performed successively in all patients.
roximal cerebral protection was applied in all but 1 patient. The 30-day death/stroke rate was
%. At 12-month follow-up neurological events did not occur; 1 patient developed a nonfatal
yocardial infarction, and another patient died from noncardiac cause. The 12-month death/
troke rate was 4.0%.
onclusions Carotid stenting under proximal cerebral protection seems to be a feasible and safe
rocedure to manage patients with severe carotid stenosis in presence of angiographic string sign.
urther prospective trials are required to prove efﬁcacy of CAS in larger study populations. (J Am
oll Cardiol Intv 2010;3:298–304) © 2010 by the American College of Cardiology Foundation
rom the *Catheterization Laboratory, Cardiology Department, Mirano Public Hospital, Mirano, Italy; †Laboratory of Invasive
ardiology, Division of Cardiology, Clinica Montevergine, Mercogliano, Italy; and the ‡Bakoulev Scientific Center for
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299igh-grade internal carotid artery (ICA) stenosis might be
ssociated with angiographic appearance of a long, thin,
apered, post-stenotic segment of markedly reduced caliber
ith reduced anterograde flow. This angiographic appear-
nce is called string sign, slim sign, or atherosclerotic
seudo-occlusion (1,2). Presence of string-sign detected at
arotid angiography has been correlated to high morbidity
nd mortality risk (3). The natural history of patients with
tring sign is poorly characterized, and therefore management
f those patients remains controversial. Previous studies in
See page 305
hich endarterectomy was performed to treat those patients
eported conflicting results. Alternatively, carotid artery
tenting (CAS), with various protection devices, has been
sed as treatment modality in string sign patients with
cceptable results (4). Nevertheless, string sign is a well-
nown anatomical and functional feature for adverse events,
nd patients presenting with string sign were excluded from
ost clinical trials on CAS. That was because of the
ossible presence of thrombus at the lesion site, which is
ssociated with elevated risk for distal embolization and
ubsequent neurological complications.
To determine the feasibility and safety of CAS with prox-
mal protection devices, which potentially minimizes the risk of
istal embolization, we evaluated the acute and 12-month
utcome of 25 patients presenting with angiographic appear-
nce of string sign.
ethods
atient population. The study cohort consisted of patients
ho underwent carotid angiography and had angiographi-
ally documented string sign in the target lesion. Indication
or treatment was set by a board certified neurologist
ogether with an interventionalist experienced in carotid
tenting. String sign was defined as the angiographic ap-
earance of a long, thin, tapered post-stenotic segment of
he ICA with markedly reduced antegrade flow in presence
f a subocclusive stenosis (2). Appearance of the string sign
ad to be certified by at least 2 interventionalists experi-
nced in carotid stenting, 1 of whom was unaware of the
atient’s clinical condition.
From October 2006 to August 2007, in 2 different
nstitutions, selective carotid angiography was performed in
5 patients (21 men [84.0%], and 4 [16.0%] women, mean
ge of 70.9  8.7 years) presenting with string sign. That
as 6.0% of the total 416 CAS procedures performed in both
nstitutions during the period of the study. Immediately after
he diagnostic angiography, CAS was attempted in all 25
atients. Twenty (80.0%) patients were symptomatic—defined
s the presence of stroke, transient ischemic attacks (TIAs), or
maurosis within 6 months before the angiography—and 5 R20.0%) were asymptomatic. The demographic, clinical, and
ngiographic data of the patients treated are summarized in
able 1.
Indications for treatment in symptomatic patients were:
ingle TIA in 5 (20%) patients, repeated and recent TIAs in
1 (44.0%), recent major stroke in 3 (12.0%), and acute
troke suitable for emergent reperfusion as indicated by the
uidelines for acute ischemic stroke management in 1
4.0%) patient (5).
rocedural details. All procedures were performed by expe-
ienced operators working in large volume centers (200
AS/year) and having large experience in both carotid
tenting (50 CAS/year) and in use of proximal protection
evices. If not already receiving therapy, all patients received
loading dose of clopidogrel (300 mg) orally; a loading dose
f aspirin (250 mg) was given only in patients not already
aking aspirin daily. Before the procedure a bolus dose of
eparin (70 to 100 IU/kg of body weight) was administered
o maintain an activated coagulation time of 250 to 300 s
hroughout the procedure. Di-
gnostic carotid and cerebral an-
iography was performed in
tandard orthogonal angio-
raphic views with the trans-
emoral approach and selective
atheterization of the common
arotid artery (CCA) (Fig. 1).
ubsequently, a diagnostic cath-
ter (4-F or 5-F) was advanced
ver a hydrophilic, floppy 0.035-
nch wire (Glidewire, Terumo
urope NV, Leuven, Belgium)
hat had been previously placed
nto the external carotid artery
ECA). This wire was ex-
hanged through the diagnostic catheter to a medium-
upport, 300-cm long, floppy-tip 0.035-inch wire (Hi-
orque SupraCore 35, Guidant, Santa Clara, California).
hen the proximal protection device—either Mo.Ma (In-
atec, Roncadelle, Italy) in 16 patients or the Gore Flow
eversal System (W. L. Gore, Inc., Flagstaff, Arizona) in 5
atients—was advanced into the CCA. In case of the
o.Ma device, the distal balloon was advanced in the
roximal part of the ECA. Application of proximal protec-
ion device was not possible in 1 patient (4.0%), because of
he presence of a type III aortic arch. This patient was
reated with a guiding catheter and a filter-type distal
rotection device. The number and type of protection
evices used are presented in Table 2. Proximal protection
as applied with the consecutive inflation of the balloons,
rst with the balloon placed in the ECA and then the
alloon placed in the CCA. Flow-blockage (in case of
o.Ma device) and flow-reversal (in case of Gore Flow
Abbreviations
and Acronyms
CAS  carotid artery
stenting
CCA  common carotid
artery
CEA  carotid
endarterectomy
ECA  external carotid
artery
ICA  internal carotid artery
MACCE  major cardiac and
cerebral event
TIA  transient ischemic
attackeversal System) were angiographically documented, and
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300ack-pressure was registered. After this, the lesion was
arefully crossed with a 0.014-inch steerable coronary
uidewire. Pre-dilation of the stenotic lesion was performed
n 17 (68.0%) patients with low-profile coronary balloons of
.5 to 3.5 mm in diameter. In all patients a single self-
xpanding stent was successfully deployed that was post-
ilated with slightly undersized balloons (5.0 to 5.5 mm in
iameter) to achieve a good stent apposition and adequate
umen diameter (Table 2, Figs. 2 and 3).
Independent neurological evaluation was routinely per-
ormed, typically by different neurologist–whoever was
n-call– before and immediately after the procedure as
ell as at discharge and at 30 days after procedure. All
atients underwent routine carotid ultrasound at 24 h and
0 days after procedure to evaluate stent patency. All
atients were prescribed aspirin (100 mg daily) indefi-
itely and clopidogrel (75 mg daily) for 30 days after
ndex procedure. Clinical follow-up was routinely sched-
led at 1 month and 6 and 12 months for all patients.
eﬁnitions. Post-procedural carotid and cerebral flow was
ategorized according to the Thrombolysis In Myocardial
Table 1. Patient Clinical and Angiographic Data (n  25)
Patient age, yrs 70.9 8.7
Age 80 yrs 10 (40.0)
Male 19 (76.0%)
Cardiovascular risk factors
Smokers 9 (36.0)
Hypertension 19 (76.0)
DM 3 (12.0)
Dyslipidemia 20 (80.0)
Family history of CAD 9 (36.0)
NIHSS 13.9 (5–30)
History of CAD 9 (36.0)
History of PAD 5 (20.0)
Previous CABG 1 (4.0)
Left internal carotid involvement 13 (52.0)
Right internal carotid involvement 12 (48.0)
Symptomatic status 20 (80.0)
Presence of thrombus 13 (52.0)
Asymptomatic 5 (100)
Symptomatic 8 (40.0)
Contralateral 50% stenosis 3 (4.0)
Calciﬁcation 16 (64.0)
Unfavorable aortic arch
Type II 12 (48.0)
Type III 1 (4.0)
Vessel tortuosity
Distal to the lesion 7 (28.0)
Proximal to the lesion 2 (8.0)
ECA stenosis 6 (24.0)
Data reported as mean SD, n (%), or mean (range).
CABG  coronary artery bypass grafting; CAD  coronary artery disease; DM  diabetes
mellitus; ECA external carotid artery; NIHSSNational Institutes of Health Stroke Scale; PADCperipheral artery disease.nfarction grading system (6). Grading of the angio-
raphic images was made by an independent investigator
ho was unaware of the clinical characteristic and the
linical outcome of the patient. Procedural success was
efined as the successful treatment of the culprit lesion in
he ICA together with restoration of normal antegrade
ow (Thrombolysis In Myocardial Infarction flow grade
). Clinical success was defined as procedural success
ithout the occurrence of any major cardiac and cerebral
vent (MACCE). A MACCE was defined as occurrence
f any death of cardiovascular or neurological cause,
yocardial infarction, new ischemic stroke, or symptom-
tic intracerebral hemorrhage. Major stroke was defined
s a stroke that caused more than 4 points worsening in
he National Institutes of Health Stroke Scale or wors-
ning of at least 1 point in the modified Rankin Scale
uring follow-up. Any other stroke that did not fulfill the
forementioned criteria was classified as minor stroke.
The procedures were performed after signed informed
onsent form was obtained from every patient or from
is/her closest relatives in cases where the patient was
eclared unable to consent.
esults
rocedural and clinical success was achieved in all patients
100%). Neurological complications during the in-hospital
eriod did not occur. One patient developed a groin
ematoma that was treated conservatively without blood
ransfusion and resolved within 5 days.
Proximal protection was successfully applied in all but 1
atient (96.0%). One patient developed acute myocardial
nfarction at day 21 after procedure that was treated suc-
essfully with primary percutaneous coronary intervention.
hus, the 30-day MACCE rate was 4.0%, whereas the
troke/death rate during the same period was 0%.
Follow-up at 12 months was available for all patients.
eurological events did not occur. One patient died from
o cardiovascular or neurological cause— bronchogenic
arcinoma—3 months after CAS procedure. The 12-
onth MACCE rate was thus 4.0%, whereas the 12-
onth death/stroke rate was 4.0%.
Routine examination by carotid duplex ultrasonography
t discharge and at 30 days showed patent stents in all 25
reated patients. Ultrasound examination at 6 months was
vailable in 19 (76.0%) patients. All stents appeared patent
ithout significant restenosis.
iscussion
re-occlusive atherosclerosis with or without presence of
hrombus is the most common cause of angiographic string
ign. It usually occurs in the very proximal part of the ICA.
ircumferential enlargement of the plaque produces hemo-
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301ynamically significant stenosis with reduction of the flow
istal to the stenosis, which leads to lumen collapse of the
istal extracranial and the intracranial ICA producing the
tring sign (7,8). Despite the angiographic narrow appear-
nce of the distal collapsed ICA, the more distal artery is
sually not diseased and resumes normal flow and diameter
fter revascularization, either surgical or endovascular (9).
String sign was observed only in 25 of 416 CAS patients
6.0%). This figure might underestimate the real incidence
f string sign. Previous studies have indicated the difficulty
f Duplex ultrasound in differentiating patients with total
cclusion of the ICA with those with string sign (1,10)
ide application of modified duplex scanning protocols in
atients with phenomenally occluded ICA might increase
Figure 1. Angiographic Appearance of String Sign
The left panel shows the external carotid artery ﬁlled with contrast, whereas t
middle and the right panel show the internal carotid artery with reduced cal
Table 2. Cerebral Protection Devises and Stents*
Protection devices
Mo. MA 16 (64.0)
Gore Flow Reversal System 8 (32.0)
FiterWire EZ 1 (4.0)
Stents
Precise 10 (40.0)
Cristallo 9 (36.0)
Carotid Wallstent 3 (12.0)
Acculink 2 (8.0)
Exponent 1 (4.0)
Data reported as n (%). *Mo.Ma, Invatec, Roncadelle, Italy; Gore Flow Reversal System, W. L. Gore,
Inc., Flagstaff, Arizona; FilterWire EZ, Boston Scientific, Natick, Massachusetts; Precise RX, Cordis,
Miami Lakes, Florida; Cristallo, Invatec; Carotid Wallstent, Boston Scientific; RX Acculink Carotidsstent, Abbott Park, Illinois; and Exponent Carotid Stent System, Minneapolis, Minnesota.he number of patients diagnosed with string sign instead of
otal occlusion of ICA (10).
Previously, patients presenting with angiographic string
ign were considered as candidates for urgent carotid end-
rterectomy (CEA). Early studies have demonstrated that
atients suffering from string sign are at higher risk for
erioperative complications and stroke when treated with
EA (3,11). By contrast, data from the NASCET (Amer-
can Symptomatic Carotid Endarterectomy Trial) showed
erioperative safety comparable to that of patients who
nderwent CEA with less severe stenosis but a lesser degree
f stroke reduction (12). Another study reported that
EA performed in the presence of string sign and critical
arotid stenosis did not affect the outcome (13). In the
CST (European Carotid Surgery Trial), symptomatic
atients with high-grade stenosis and post-stenotic nar-
owing of the ICA who were treated medically showed
ignificantly lower rates of ipsilateral stroke compared
ith those with lesser degree of stenosis (14). This led
ome centers to abandon emergent CEA management
nd treat those patients pharmacologically with antico-
gulation and/or aspirin (9).
Percutaneous treatment of patients with string sign
ith CAS is also a matter of contradiction. It has been
ssociated with a higher risk of thromboembolic compli-
ations and has even been considered as a contraindica-
ion for CAS. This was due to the possible presence of
hrombus or ruptured, unstable plaque leading to the
ernal carotid artery shows a tight, ﬂow-limiting lesion at the ostium. The
hereas the contrast in the external carotid artery is already washed away.he inttring sign itself, which might predispose to elevated rates
o
s
s
c
i
s
i
r
t
p
s
t
t
e
o
c
e
a
a
c
t
q
t
c
d
p
m
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 3 , N O . 3 , 2 0 1 0
M A R C H 2 0 1 0 : 2 9 8 – 3 0 4
Nikas et al.
Carotid Stenting in Patients With String Sign
302f cerebral embolism and stroke. Most of the CAS
tudies and registries cite string sign among their exclu-
ion criteria (15–17). Previous studies have reported,
ontrary to the dominant clinical impression, encourag-
ng results for patients with string sign undergoing carotid
tenting (4,18). The relatively low rate of MACCE observed
n our study confirm the encouraging results of these
eports. The increasing experience in CAS techniques,
he improvement of devices, and the availability of new
roximal cerebral protection systems led us to the as-
umption that CAS might be a feasible and safe option to
reat symptomatic patients with string sign. Given that
he majority of the patients were symptomatic with
levated risk for complications and the degree of difficulty
Figure 2. Carotid Stenting Procedure With Proximal Protection Device in a
Angiographic appearance of string sign at baseline (left), during proximal cere
1 balloon occluding the common carotid artery and staining of a modest quan
protection device (right).
Figure 3. Intracerebral Angiography Before and After Carotid Stenting in a
Intracerebral angiography obtained from the patient shown in Figure 2 with s
intracranial ﬂow of the left internal carotid artery at baseline. The middle pan
and the right panel shows ﬂow after stent implantation in the left carotid artery.f these procedures, the outcome of our patients is
onsidered favorable (19). A significant role in these
ncouraging results was played by the close cooperation
mong different specialties (cardiologists, neurologists,
nd vascular surgeons) managing patients with advanced
arotid artery disease, collaborating within a solid mul-
idisciplinary team. Careful patient selection and ade-
uate experience in complex CAS procedures as well as in
he usage of proximal protection devices should be
onsidered mandatory to achieve low rates of periproce-
ural complications.
Previously, the annual risk of stroke in symptomatic
atients with ICA near-occlusion who have been treated
edically was 11.1% (12). Even though direct comparison
nt With String Sign
rotection (middle) with 1 balloon occluding the external carotid artery and
f contrast. Final angiographic result after stent placement and removal of the
nt With String Sign
e injection into the common carotid arteries. The left panel shows reduced
ws intracranial arteries after injection of the right common carotid artery,Patie
bral p
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303etween previous data and ours cannot be done, the low
nnual death/stroke rates observed in our study demonstrate
hat CAS might be a considerable treatment option in
ymptomatic patients with string sign. It should be noted,
owever, that the small numbers of patients included in this
tudy together with its retrospective nature signify that
arger, prospective trials, testing CAS in patients with string
ign, are required before real clinical efficacy of this endo-
ascular treatment modality is granted.
In patients with string sign, the indications for perform-
ng CAS are yet unclear, especially for the asymptomatic
nes. The main reason for proceeding with CAS in the
symptomatic patients was the angiographically docu-
ented presence of fresh thrombus at the site of carotid
tenosis. In cases like that, the multidisciplinary team—
onsisting of the interventionalist, a vascular surgeon, and a
eurologist—felt that there was high probability for embo-
ization and unanimously decided to proceed into CAS.
Proximal protection devices were used in 96.0% of the
ases. Use of proximal protection devices seems to be better
n cases of string sign, because they offer the advantage of
omplete protection during all phases of the procedure, even
efore lesion crossing. Application of a distal type of
rotection device—either filter or occlusion balloon—
ould be rather difficult, because the estimation of the
aliber or the anatomy of the distal ICA to accommodate a
istal type of protection device is almost impossible. Fur-
hermore, crossing the culprit carotid lesion with a filter or
cclusion balloon could create emboli to the brain with
otentially devastating results, especially in the presence of
resh thrombus. Importantly, as seen from our series,
ignificant stenosis of the ECA is not a contraindication for
pplication of the proximal protection devices. In 6 of 24
atients treated with proximal protection device who had
ignificant ECA stenosis, we identified no complications.
t the end of the procedure, ECA remained intact without
ny damage. This observation is in accordance with previous
eports indicating that significant ECA stenosis does not
reclude application of proximal clamping as protection
evice during CAS (20).
tudy limitations. The major limitation of the study is its
etrospective nature. The number of patients included in
his study is small, and therefore the comparison of the
resent results with other published reports must be inter-
reted with great caution. Not all patients had ultrasound
ollow-up at 6-months; therefore, asymptomatic restenosis
ight have not been identified in the rest of the patients.
onclusions
arotid stenting in patients with string sign seems to be a
easible alternative to CEA, with low procedural complica-
ions and favorable outcome. Application of carotid stenting
n all patients requires careful patient selection from anxperienced multidisciplinary team able to identify and treat
atients with advanced carotid artery disease. Whether
niversal application of carotid stenting as a treatment
odality in patients with carotid disease and sting sign will
educe future stroke events needs to be clarified further with
arger controlled trials.
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